$69 non-ATF Mobile

CardieX Limited (ASX:CDX) updated about the expansion of two clinical trials with its existing customers Bayer and AstraZeneca.

ATCOR Medical, a 100 percent subsidiary of CDX is supporting these trails by providing the lease of its data management services and XCEL device to both customer companies for the entire period of the trial.

The total values of USD 0.34 million and USD 1.261 million comprises of the ongoing trial price as well as the value of ATCOR’s original contract with AstraZeneca (in October 2018) and Bayer (in December 2017), respectively.

Gold MTF non-AMP

 

 

All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK